spacer
home > ict > spring 2017 > odd one out
PUBLICATIONS
International Clinical Trials

Odd One Out

Over recent years, permissive science, innovative trial methodology, evolving regulatory sentiments and increasingly sophisticated commercialisation have all contributed to drug development. However, some challenges still remain. Poor understanding regarding the natural history of the proposed indication due to few observational trials studying disease progression, recruiting and retaining patients and investigators as well as regulatory uncertainties can all prove difficult, to detail just a few.

Facilitating Enrolment

A smaller selection of patients and, occasionally, a decreased likelihood of finding and engaging patient advocacy groups, means that identifying and locating participants can be extremely perplexing for orphan drug researchers.

The benefits of working with patient advocy groups are invaluable to researchers when attempting to seek out participants. These groups usually involve patient caregivers or relatives, as well as doctors and key opinion leaders (KOLs) in the specific indication. It is crucial for CROs, sponsors and investigators to reach out and communicate with these groups – especially during the initial stages of a protocol design – because having their cooperation at this point can be crucial to the success of a trial. By taking the time to meet and speak with members of any relevant groups, researchers can gain valuable insight into a particular condition – including what life is like for potential participants, as well as what is important to the caregivers and others in the patient’s network.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jeffrey Zucker is Senior Vice President of Global Clinical Operations at Worldwide Clinical Trials. His current responsibilities include growing and continually improving the company’s global and site feasibility capabilities. Jeffrey also oversees the evolving Patient Recruitment and Site Relations departments and has been in the clinical research industry for 20 years.
spacer
Zeffrey Zucker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SCORR Marketing and Applied Clinical Trials Release Report on Collaborative R&D in the Drug Development Industry

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report. The report details the extent to which collaboration in the life sciences industry occurs and provides insight into the factors that influence this collaboration
More info >>

White Papers

PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content

Phlexglobal Ltd

Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive. As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>

 
Industry Events

9th Global Drug Delivery & Formulation Summit

12-14 March 2018, Maritim proArte Hotel Berlin

The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement